Page 42 - EndoProxy2012_final

endo | 100 Endo Boulevard | Chadds Ford, Pennsylvania 19317 36
4 These options and restricted stock units were granted in 2011 based on the Company’s 2010 LTI compensation payout.
The 2011 equity incentive payout was made in February 2012 and is shown in more detail below:
a The exercise price is equal to the closing price on the date of grant, which was February 22, 2012.
b The amounts shown in this column represent approximately 50% RSUs and 50% PSUs on the date of grant.
c The amounts shown in this column include the fair value under ASC 718 of the 2011 option awards on the date
of grant determined using the Black-Scholes or Monte-Carlo variant valuation model, as appropriate. Addition-
ally, amounts reflect the grant-date fair value of the PSUs which include both a performance and market-based
variable as defined within ASC 718. Although the fair value of executive award grants listed above has been de-
termined in accordance with the applicable accounting standards, values may not be indicative of the fair value
observed in a willing buyer / willing seller market transaction.
5 The amounts shown in this column represent the fair value under ASC 718 of awards granted in 2011 valued on the
date of grant (even if not yet vested) determined using the Black-Scholes or Monte-Carlo variant valuation model, as
appropriate.
6 For the current NEOs, the amounts shown in this column represent the maximum IC payout as approved by the Board.
7 For the current NEOs, the amounts shown in this column represent the maximum number of shares related to our PSUs
that could ultimately be released at the end of the three-year performance period.
See “COMPENSATION DISCUSSION AND ANALYSIS” above regarding the material terms, determining amounts payable,
vesting schedule and other material conditions of these grants.
Outstanding Equity Awards at December 31, 2011
The following table summarizes the number of securities underlying outstanding plan awards for the NEOs during the year
ended December 31, 2011:
Name
2011 Long-Term Equity
Incentive Compensation:
Number of Securities
Underlying Stock Options
(#)
Exercise or Base Price of
Option Awards ($/Sh)(a)
2011 Long-Term Equity
Incentive Compensation:
Restricted Stock Units
(RSU) and Performance
Share Units (PSU) (#)(b)
Grant Date Fair Value of
RSU, PSU & Option Awards
(c)
David P. Holveck 173,940 $ 34.70 105,668 $ 5,500,000
Alan G. Levin 54,905 $ 34.70 33,354 $ 1,736,100
Julie H. McHugh 53,131 $ 34.70 32,276 $ 1,680,000
Ivan P. Gergel, M.D. 44,250 $ 34.70 26,882 $ 1,399,200
Caroline B. Manogue 42,694 $ 34.70 25,936 $ 1,350,000
Option Awards Stock Awards
Name
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)(1)
Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)
Option
Exercise
Price ($)
Option
Expiration
Date
Number of
Shares of
Stock That
Have Not
Vested (#)
Market Value
of Shares of
Stock That
Have Not
Vested ($)(7)
Equity
Incentive
Plan Awards:
Number of
Unearned
Shares, Units
or Other
Rights That
Have Not
Vested (#)
Equity Incentive
Plan Awards:
Market or Payout
Value of Unearned
Shares, Units or
Other Rights That
Have Not Vested
($)(8)
David P.
Holveck
- 161,983 - $ 33.98 23-Feb-2021 - $ - - $ -
42,184 126,549 - $ 20.61 19-Feb-2020 - $ - - $ -
191,407 191,406 - $ 19.93 26-Feb-2019 - $ - - $ -
141,474 47,158 - $ 24.41 01-Apr-2018 - $ - - $ -
- - - $ - - 166,924 (2) $ 5,763,886 - $ -
- - - $ - - - $ - 111,350 (2) $ 3,844,916
Alan G.
Levin
- 51,074 - $ 33.98 23-Feb-2021 - $ - - $ -
15,152 45,454 - $ 20.61 19-Feb-2020 - $ - - $ -
4,978 9,954 - $ 20.09 28-Jul-2019 - $ - - $ -
16,626 33,251 - $ 16.51 01-Jun-2019 - $ - - $ -
- - - $ - - 59,467 (3) $ 2,053,396 - $ -
- - - $ - - - $ - 37,717 (3) $ 1,302,368
Julie H.
McHugh
- 49,128 - $ 33.98 23-Feb-2021 - $ - - $ -
30,070 90,209 - $ 23.81 15-Mar-2020 - $ - - $ -
- - - $ - - 26,277 (4) $ 907,345 - $ -
- - - $ - - - $ - 15,745 (4) $ 543,675